Capstone Investment Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-19,449	Closed	-$171K	–	1563
2023 Q4	$171K	Buy	+19,449	New	+$171K	﹤0.01%	879